milyon88 app apps download free Lawyer says ex-Temple basketball standout Hysier Miller met with NCAA for hours amid gambling probeCellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

Towards Viksit Bharat: Redefining India's Foreign Policy LandscapeNEW YORK , Dec. 15, 2024 /PRNewswire/ -- The global noise detection and monitoring market size is estimated to grow by USD 7.19 billion from 2024 to 2028, according to Technavio. The market is estimated to grow at a CAGR of 6.85% during the forecast period. The report provides a comprehensive forecast of key segments below- Segmentation Overview Get a glance at the market contribution of rest of the segments - Download a FREE Sample Report in minutes! 1.1 Fastest growing segment: The global noise detection and monitoring market caters to various industries, with significant demand coming from manufacturing, oil and gas, mining, construction, and aerospace sectors. These industries employ large workforces engaged in noisy tasks, such as grinding, blasting, drilling, hammering, drop forging, and crushing, which can lead to hearing loss from prolonged exposure. Tools like drills, chainsaws, detonators, and pneumatics generate loud noises, necessitating regular monitoring of noise levels and provision of Personal Protective Equipment (PPE) for workers. The manufacturing industry, in particular, is a major contributor to the market due to its high-decibel environments. Vendors offer innovative solutions, such as Honeywell's in-ear dosimetry system, which measures noise at the eardrum and tracks potential hearing loss in real-time, ensuring regulatory compliance and worker safety. The growing demand for noise monitoring devices in industrial applications is expected to fuel market growth during the forecast period. Analyst Review The Noise Detection and Monitoring Market encompasses technologies and solutions designed to identify and manage noise levels in various environments. This market is driven by growing concerns over Environmental Impact and Occupational Safety, as urbanization increases the prevalence of noise pollution from machines, speakers, music systems, horns, and other devices. Smart City projects are also significant contributors, integrating noise monitoring systems to enhance liveability and promote Corporate Responsibility. Applications in Healthcare are essential, as prolonged exposure to noise emissions can lead to health issues. However, the Cost of Implementation and Integration Difficulties pose challenges. Limited Standardisation and Sampling method variations, as well as Precision type and Connectivity requirements, add complexity. Core competencies of key players include advanced algorithms, real-time data analysis, and user-friendly interfaces. Alliances and partnerships are crucial for market expansion and technological advancements. The Noise Monitoring Industry continues to evolve, addressing the needs of human health and wildlife protection. Market Overview The Noise Detection and Monitoring market encompasses solutions and technologies designed to measure and manage noise emissions, with applications in Environmental Impact, Occupational Safety, and Urbanization. Noise sources include machines, speakers, music systems, horns, and various devices. The market caters to both human health and wildlife, with solutions ranging from portable noise monitoring to permanent installations. Key drivers include rising sound pollution levels, smart city investments, and corporate responsibility. Challenges include cost of implementation, integration difficulties, and limited standardization. Components include hardware (sound level meters, wind noise suppressors) and software (artificial neural networks, sound analysis algorithms). Subsegments include building acoustics, sampling methods, precision types, connectivity solutions, and sound pollution monitoring systems. Applications extend to healthcare, where noise monitoring tools help mitigate negative impacts on human health, including heart diseases, cardiovascular problems, cognitive impairment, stress, diabetes, anxiety, and depression. Regulatory acts play a crucial role in market growth. Solutions offer real-time data transmission via WIFI or Ethernet, catering to commercial and residential sectors. Portable and battery-based devices enable short-term, medium-term, and long-term monitoring. Core competencies include advanced technology, customization, and user-friendly interfaces. Alliances, directories, and databases expand market reach. To understand more about this market- Download a FREE Sample Report in minutes! 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Venodr Landscape 11 Vendor Analysis 11.1 Extech Instruments 11.2 Pulsar Instruments 11.3 3M Company 11.4 RION Co. Ltd 11.5 Bruel & Kjaer 11.6 Cirrus Research Plc 11.7Castle Group Ltd 11.8 Casella Inc. 11.9 SKF Group, Kimo Instrument 11.10 B &K Precision Corporation 11.11 ACOEM Group 11.12 Amphenol Corporation 11.13 Cesva Instruments S.L.U 11.14 Exair Corporation 11.15 Honeywell International Inc 11.16 Hottinger Bruel & Kjaer A/S 11.17 HT Italia S.r.l 11.18 MTS Systems Corporation 11.19 NTi Audio AG 11.20 PCE Deutschland GmbH. 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: media@technavio.com Website: www.technavio.com/ View original content to download multimedia: https://www.prnewswire.com/news-releases/noise-detection-and-monitoring-market-size-to-increase-by-usd-7-19-billion-between-2023-to-2028--market-segmentation-by-end-user-component-geography---technavio-302331227.html SOURCE TechnavioTHOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen

5 top tech gifts for the holidays

BOULDER, Colo. — A 72-year-old lifelong Colorado fan with end-stage kidney failure waited to the side of the field in his wheelchair for Travis Hunter and the rest of the Buffaloes. One by one, players strolled over and signed a football for Riley Rhoades, his face lighting up with each signature. Standing close by and taking in the scene was Jeremy Bloom. He's become a wish facilitator for older adults. Bloom, the former Colorado wide receiver and Olympic freestyle skier, started the Wish of a Lifetime foundation in 2008, which has made thousands of aspirations turn into reality for older adults. The list of granted wishes range from taking veterans back to the beaches of Normandy to helping late-in-life authors publish a book. He's staged concerts for musicians, assisted some in daredevil feats such as jumping out of an airplane and even lined up a meeting between an Olympic medalist and former President Barack Obama. For Rhoades, his wish was simply to return to Folsom Field again, the place where he used to have season tickets but hasn't attended a game since 2004. "Everybody has somebody in their life —a grandparent, friend, neighbor — at that age where you wish you had more resources to help," said Bloom, whose college career was cut short two decades ago when the NCAA denied his reinstatement to play football and still ski professionally after receiving endorsement money to fuel his Olympic dreams. "Nothing can compare to seeing someone else's eyes light up because you helped make their dream come true." The foundation is a tribute to his grandparents. But the concept began to take root when he was a teenager. He was in Japan for a World Cup freestyle skiing competition when a woman tried to hop on a crowded bus. There was no room, but everyone in front rose from their seats to make space. That stuck with him, along with seeing these acts of kindness for older adults all over Europe and Asia as he traveled. An idea formed — bring that same level of appreciation to the United States, with a wish-granting element. Bloom's organization has been a charitable affiliate of AARP since 2020. It was the yearning of Rhoades that brought the two of them to Folsom Field last weekend. Rhoades, who had season tickets at Colorado for 27 years, wanted to see the Buffaloes in person after watching the team's resurgence on television. A few years ago, Rhoades, who was born with spina bifida, was diagnosed with end-stage renal failure. Being among the 54,646 fans Saturday stirred up plenty of emotions for Rhoades, as he watched the 16th-ranked Buffaloes (8-2, 6-1 Big 12, No. 16 CFP) beat Utah. Colorado remains in the race for not only a conference title but a spot in the College Football Playoff. "It's just great to be back here again," Rhoades said as he pointed out the section where he used to watch games. "It's just ... so cool." For Bloom, the success that coach Deion Sanders has brought to the program means more reunions with teammates as they pass through town. "I've been through many years where nobody comes to visit," Bloom said. "It's fun that Boulder has become the epicenter of college football." Leading the way for Colorado this season have been quarterback Shedeur Sanders and two-way star Hunter, who's the Heisman Trophy frontrunner. But what particularly pleases Bloom is that Sanders, Hunter and the rest of college football players are able to finally profit through name, image and likeness. In his day, Bloom got caught in the NCAA crosshairs for wanting to play both sports and to have sponsors in one (skiing) so he could fund his Olympic aspirations. How time have changed. "I'm just really grateful that this generation of athletes gets to monetize their skills and ability," said Bloom, who finished sixth in moguls at the 2006 Winter Games in Italy. "It's the right thing." He's thrown his passion into fulfilling wishes such as learning ballet, riding in a Formula 1 pace car or taking a flight in a fighter jet. He's also helped reconnect families and friends, including a reunion for a trio of centenarian sisters who hadn't seen each other in more than a decade. This granted wish has stuck with Bloom: A person in Alabama wasn't able to travel after being diagnosed with end-of-life emphysema. So he asked for postcards to be sent, just to learn what made someone's town so special. He received 2,000 postcards from 26 different countries. "There's no end to the things that they've done for us in the world," Bloom said of older adults. "We're one of the organizations that reminds them that their dreams still do matter and that we still appreciate them and we cherish them." Get local news delivered to your inbox!

Ex-Colorado footballer Bloom dedicates time to fulfilling wishes for older adultsNone

Manhattan police have obtained a warrant for the arrest of 26-year-old Luigi Nicholas Mangione , suspect in the killing of UnitedHealthcare CEO Brian Thompson . Mangione was arrested at a McDonald’s in Altoona, Pennsylvania, while carrying a gun, mask and writings linking him to the ambush. Mangione is being held without bail in Pennsylvania on charges of possession of an unlicensed firearm, forgery and providing false identification to police. Late Monday, Manhattan prosecutors charged him with five counts, including murder, criminal possession of a weapon and criminal possession of a forged instrument. Here's the latest: White House press secretary Karine Jean-Pierre says “violence to combat any sort of corporate greed is unacceptable” and the White House will “continue to condemn any form of violence.” She declined to comment on the investigation into the Dec. 4 shooting death of UnitedHealthcare CEO Brian Thompson or reports that writings belonging to the suspect, Luigi Mangione, said insurance companies care more about profits than their customers. “This is horrific,” Jean-Pierre said of the fatal shooting of Thompson as he walked in Manhattan. He didn’t appear to say anything as deputies led him to a waiting car outside. “I’m deeply grateful to the men and women of law enforcement whose efforts to solve the horrific murder of Brian Thompson led to the arrest of a suspect in Pennsylvania,” Gov. Hochul said in the statement. “I am coordinating with the District Attorney’s Office and will sign a request for a governor’s warrant to ensure this individual is tried and held accountable. Public safety is my top priority and I’ll do everything in my power to keep the streets of New York safe.” That’s according to a spokesperson for the governor who said Gov. Hochul will do it as soon as possible. Luigi Nicholas Mangione, the suspect in the fatal shooting of a healthcare executive in New York City, apparently was living a charmed life: the grandson of a wealthy real estate developer, valedictorian of his elite Baltimore prep school and with degrees from one of the nation’s top private universities. Friends at an exclusive co-living space at the edge of touristy Waikiki in Hawaii where the 26-year-old Mangione once lived widely considered him a “great guy,” and pictures on his social media accounts show a fit, smiling, handsome young man on beaches and at parties. Now, investigators in New York and Pennsylvania are working to piece together why Mangione may have diverged from this path to make the violent and radical decision to gun down UnitedHealthcare CEO Brian Thompson in a brazen attack on a Manhattan street. The killing sparked widespread discussions about corporate greed, unfairness in the medical insurance industry and even inspired folk-hero sentiment toward his killer. ▶ Read more about Luigi Mangione Peter Weeks, the Blair County district attorney, says he’ll work with New York officials to try to return suspect Luigi Mangione there to face charges. Weeks said the New York charges are “more serious” than in Blair County. “We believe their charges take precedent,” Weeks said, promising to do what’s needed to accommodate New York’s prosecution first. Weeks spoke to reporters after a brief hearing at which a defense lawyer said Mangione will fight extradition. The defense asked for a hearing on the issue. In the meantime, Mangione will be detained at a state prison in western Pennsylvania. Manhattan District Attorney Alvin Bragg’s office said Tuesday it will seek a Governor’s warrant to secure Mangione’s extradition to Manhattan. Under state law, New York Gov. Kathy Hochul can issue a warrant of arrest demanding Mangione’s return to the state. Such a warrant must recite the facts necessary to the validity of its issuance and be sealed with the state seal. It would then be presented to law enforcement in Pennsylvania to expedite Mangione’s return to New York. But Blair County District Attorney Peter Weeks says it won’t be a substantial barrier to returning Mangione to New York. He noted that defendants contest extradition “all the time,” including in simple retail theft cases. Dickey, his defense lawyer, questioned whether the second-degree murder charge filed in New York might be eligible for bail under Pennsylvania law, but prosecutors raised concerns about both public safety and Mangione being a potential flight risk, and the judge denied it. Mangione will continue to be housed at a state prison in Huntingdon. He has 14 days to challenge the detention. Prosecutors, meanwhile, have a month to seek a governor’s warrant out of New York. Mangione, wearing an orange jumpsuit, mostly stared straight ahead at the hearing, occasionally consulting papers, rocking in his chair, or looking back at the gallery. At one point, he began to speak to respond to the court discussion, but was quieted by his lawyer. Luigi Mangione, 26, has also been denied bail at a brief court hearing in western Pennsylvania. He has 14 days to challenge the bail decision. That’s with some intervention from owner Elon Musk. The account, which hasn’t posted since June, was briefly suspended by X. But after a user inquired about it in a post Monday, Musk responded “This happened without my knowledge. Looking into it.” The account was later reinstated. Other social media companies such as Meta have removed his accounts. According to X rules, the platform removes “any accounts maintained by individual perpetrators of terrorist, violent extremist, or mass violent attacks, as well as any accounts glorifying the perpetrator(s), or dedicated to sharing manifestos and/or third party links where related content is hosted.” Mangione is not accused of perpetrating a terrorist or mass attack — he has been charged with murder — and his account doesn’t appear to share any writings about the case. He shouted something that was partly unintelligible, but referred to an “insult to the intelligence of the American people.” He’s there for an arraignment on local charges stemming from his arrest Monday. He was dressed in an orange jumpsuit as officers led him from a vehicle into the courthouse. Local defense lawyer Thomas Dickey is expected to represent the 26-year-old at a Tuesday afternoon hearing at the Blair County Courthouse. Dickey declined comment before the hearing. Mangione could have the Pennsylvania charges read aloud to him and may be asked to enter a plea. They include possession of an unlicensed firearm, forgery and providing false identification to police. In New York, he was charged late Monday with murder in the death of UnitedHealthcare’s CEO Brian Thompson. Mangione likely was motivated by his anger with what he called “parasitic” health insurance companies and a disdain with corporate greed, said a a law enforcement bulletin obtained by The Associated Press. He wrote that the U.S. has the most expensive healthcare system in the world and that the profits of major corporations continue to rise while “our life expectancy” does not, according to the bulletin, based on a review of the suspect’s hand-written notes and social media postings. He appeared to view the targeted killing of the UnitedHealthcare CEO as a symbolic takedown, asserting in his note that he is the “first to face it with such brutal honesty,” the bulletin said. Mangione called “Unabomber” Ted Kaczynski a “political revolutionary” and may have found inspiration from the man who carried out a series of bombings while railing against modern society and technology, the document said. A felony warrant filed in New York cites Altoona Officer Christy Wasser as saying she found the writings along with a semi-automatic pistol and an apparent silencer. The filing echoes earlier statements from NYPD Chief of Detectives Joseph Kenny who said Mangione had a three-page, handwritten document that shows “some ill will toward corporate America.” Mangione is now charged in Pennsylvania with being a fugitive of justice. A customer at the McDonald’s in Altoona, Pennsylvania, where Mangione was arrested said one of his friends had commented beforehand that the man looked like the suspect wanted for the shooting in New York City. “It started out almost a little bit like a joke, my one friend thought he looked like the shooter,” said the customer, who declined to give his full name, on Tuesday. “It wasn’t really a joke, but we laughed about it,” he added. The warrant on murder and other charges is a step that could help expedite his extradition from Pennsylvania. In court papers made public Tuesday, a New York City police detective reiterated key findings in the investigation he said tied Mangione to the killing, including surveillance footage and a fake ID he used to check into a Manhattan hostel on Nov. 24. Police officers in Altoona, Pennsylvania, found that ID when they arrested Mangione on Monday. Mangione is being held without bail in Pennsylvania on charges of possession of an unlicensed firearm, forgery and providing false identification to police. Late Monday, Manhattan prosecutors charged him with five counts, including murder, criminal possession of a weapon and criminal possession of a forged instrument. Mangione doesn’t yet have a lawyer who can speak on his behalf, court officials said. Images of Mangione released Tuesday by Pennsylvania State Police showed him pulling down his mask in the corner of the McDonald’s while holding what appeared to be hash browns and wearing a winter jacket and ski cap. In another photo from a holding cell, he stood unsmiling with rumpled hair. Mangione’s cousin, Maryland lawmaker Nino Mangione, announced Tuesday morning that he’s postponing a fundraiser planned later this week at the Hayfields Country Club north of Baltimore, which was purchased by the Mangione family in 1986. “Because of the nature of this terrible situation involving my Cousin I do not believe it is appropriate to hold my fundraising event scheduled for this Thursday at Hayfields,” Nino Mangione said in a social media post. “I want to thank you for your thoughts, prayers, and support. My family and I are heartbroken and ask that you remember the family of Mr. Thompson in your prayers. Thank you.” Officers used New York City’s muscular surveillance system . Investigators analyzed DNA samples, fingerprints and internet addresses. Police went door to door looking for witnesses. When an arrest came five days later , those sprawling investigative efforts shared credit with an alert civilian’s instincts. A customer at a McDonald’s restaurant in Pennsylvania noticed another patron who resembled the man in the oblique security-camera photos New York police had publicized. He remains jailed in Pennsylvania, where he was initially charged with possession of an unlicensed firearm, forgery and providing false identification to police. By late Monday evening, prosecutors in Manhattan had added a charge of murder, according to an online court docket. It’s unclear whether Luigi Nicholas Mangione has an attorney who can comment on the allegations. Asked at Monday’s arraignment whether he needed a public defender, Mangione asked whether he could “answer that at a future date.”

40cr devotees to visit Maha Kumbh but govt making preps for 100 cr: Yogi

FBI Director Wray says he intends to resign at the end of Biden's term in JanuaryMarsh & McLennan Cos. stock underperforms Tuesday when compared to competitors